Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...
Standard ADC components seldom provide enough flexibility to meet the conflicting needs of today’s medical designs. By Ian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback